Federal
Register Notices > Notice
of Registration - 2005 > Penick Corporation, Inc.
FR Doc E5-6607 [Federal Register: November 29, 2005 (Volume 70,
Number 228)] [Notices] [Page 71560] From the Federal Register Online
via GPO Access [wais.access.gpo.gov] [DOCID:fr29no05-100]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 14, 2005, and published in the Federal
Register on April 25, 2005 (70 FR 10683), Penick Corporation, Inc.,
158 Mount Olivet Avenue, Newark, New Jersey, 07114, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic class of controlled
substances listed in Schedule II:
Drug |
Schedule |
Cocaine (9041) |
II |
Codeine (9050) |
II |
Dihydrocodeine (9120) |
II |
Oxycodone (9143) |
II |
Hydromorphone (9150) |
II |
Ecgonine (9180) |
II |
Hydrocodone (9193) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Oxymorphone (9652) |
II |
The company plans to manufacture the listed bulk controlled
substances in bulk for distribution to its customers.
Following the Notice of Application publication on April 25, 2005,
(70 FR 17472-17473), Penick Corporation, 158 Mount Olivet Avenue,
Newark, New Jersey 07114, relocated its operations to 33 Industrial
Park Road, Pennsville, New Jersey 08070 on May 18, 2005. DEA conducted
a full investigation and inspection of the company's security which
was found to be in compliance with all required regulations.
One comment was received; however, the comment was not relevant to
the company's current activities as a manufacturer of Schedule II
controlled substances.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the registration of Penick
Corporation to manufacture the listed basic class of controlled
substances is consistent with the public interest at this time. DEA
has investigated Penick Corporation to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substances listed.
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E5-6607 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|